Skip to content
NewsBlazeAU – Lifestyle
Author:
Accro Bioscience (Suzhou) Limited
Accro Bioscience Announces Inclusion of AC-101 tablets in the NMPA CDE’s “Caring Plan-Extension” Pilot Program for Rare Disease Drug Development
September 13, 2026
AC-201 for Vitiligo: Accro Bioscience Secures IND Clearance for Trials
September 8, 2026